| Views | |
|---|---|
| Daratumumab for treatment‐refractory antibody‐mediated diseases in neurology | 34 |
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| Daratumumab for treatment‐refractory antibody‐mediated diseases in neurology | 0 | 0 | 11 | 3 | 14 | 5 | 1 |
| Views | |
|---|---|
| 2022_Scheibe_etal.pdf | 15 |
